Radiological Investigation III: Pulmonary Angiogram and PET Scan
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Cancer Prevention
Pulmonary Function Tests
Radiological Investigation I: X-ray and CT
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 10, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
Renée Manser1, Anne Lethaby, Louis B Irving
1Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, St Andrew's Place, East Melbourne 3002, Victoria, and Department of Respiratory Medicine, Royal Melbourne Hospital, Melbourne, Australia. Renee.Manser@petermac.org.
Lung cancer screening with chest X-rays or sputum cytology does not reduce mortality. However, annual low-dose computed tomography (CT) screening shows promise for high-risk smokers, though more data on cost-effectiveness and broader applicability are needed.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: